Cellares
Latest round
- Series D
Last raised
- Jun 2026
Total raised
- $683M
Investors
- 22
About Cellares
a. Cellares operates as an integrated development and manufacturing organization (IDMO) that focuses on developing and manufacturing a cell shuttle to automate cell therapy. In June 2026, Cellares Corp. The company is developing a cell shuttle solution to overcome the limitations associated with manufacturing cell therapies for patients in need. Cellares' proprietary platform, Cell Shuttle, a modular and automated solution comprising hardware, software, robotics, and consumables, can produce 10 patient doses and enables end-to-end automation of the labor- and time-intensive process that creates cell therapies, including CAR-T, used to treat blood cancers by modifying and growing cells from the patient's own immune system to attack cancer cells. PACT Pharma and the Fred Hutchinson Cancer Research Center have joined Cellares' partnership program to participate in user studies, inform system specifications, and provide feedback on their platform to help ensure product-market fit. Cellares generates revenue through its IDMO (Integrated Development and Manufacturing Organization) services, offering automated cell therapy manufacturing via the Cell Shuttle™ platform. Additional revenue streams include licensing its advanced manufacturing technology, selling proprietary consumable cartridges, and providing software solutions like Cell Q™ for process control and analytics.
Who invested in Cellares
22 investors across 5 rounds
See all investors in Cellares
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cellares
Who invested in Cellares?
Cellares has 22 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellares raised?
Cellares has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Cellares last raise money?
Cellares's most recent round on record is a Series D, in Jun 2026.
What does Cellares do?
Cellares is a biotechnology company.
Where is Cellares headquartered?
Cellares is headquartered in South San Francisco, US.
Which VCs invest in companies like Cellares?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cellares's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Cellares? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.